Expression of Interest for Partnerships for the Development of Hi-Tech Pharmaceutical Industry in Mauritius
The setting up of the Mauritius Institute of Biotechnology Ltd (“MIBL”) with a seed capital of around USD 25 million was announced by the Government of Mauritius in the 2021-2022 budget speech. The mandate of the MIBL was extended during the 2022-2023 budget speech to include more segments beyond vaccine manufacturing as mentioned below. In […]